Cargando…
Drug repurposing against SARS-CoV-2 using computational approaches
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has generated a critical need for treatments to reduce morbidity and mortality associated with this disease. However, traditional drug development takes many years, which is not practical solution given the current pandemic. T...
Autores principales: | Kumar, Sumit, Kovalenko, Svitlana, Bhardwaj, Shakshi, Sethi, Aaftaab, Gorobets, Nikolay Yu., Desenko, Sergey M., Poonam, Rathi, Brijesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830191/ https://www.ncbi.nlm.nih.gov/pubmed/35151891 http://dx.doi.org/10.1016/j.drudis.2022.02.004 |
Ejemplares similares
-
Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022) -
Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022) -
Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022) -
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022) -
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021)